12.65SEK-1.90%Mkt Cap: —P/E: —2d ago
Saniona AB (publ), a clinical-stage biopharmaceutical company, focuses on discovering, developing, and delivering innovative treatments for neurological and psychiatric disorders in Ireland, the United States, Germany, D…
Industry Peers
Healthcare$1.14TUSDP/E 43.0
$658.89BUSDP/E 31.7
$462.68BUSDP/E 74.0
$375.50BUSDP/E 122.7
$341.92BUSDP/E 24.5
$348.81BUSDP/E 25.0
$279.13BUSDP/E 22.3
$274.07BUSDP/E 23.6
$240.45BUSDP/E 24.5
$231.49BUSDP/E 24.5
$238.75BUSDP/E 27.4
$226.85BUSDP/E 33.1
$190.75BUSDP/E 11.3
$198.81BUSDP/E 36.9
$183.02BUSD
$160.96BUSDP/E 37.2
$151.78BUSDP/E 38.6
$142.49BUSDP/E 45.6
$139.84BUSDP/E 32.2
$138.11BUSDP/E 14.9
Key Statistics
Company
Market Cap—
Enterprise Value116.07M $
Revenue (TTM)41.06M $
Gross Profit40.51M $
Net Income (TTM)21.00M $
Revenue/Share0.3036 USD
Last Price12.65 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees43
CountryGB
SectorHealthcare
Industry—
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA5.09
EV/Revenue2.83
P/S—
P/B2.92
EPS (TTM)-7.39
EPS (Forward)—
52W Range
12.5626% of range12.89
52W High12.89 SEK
52W Low12.56 SEK
Profitability
Gross Margin98.66%
Oper. Margin-1185.04%
EBITDA Margin55.52%
Profit Margin51.14%
ROE52.22%
ROA30.07%
Growth
Revenue Growth-52.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF24.46M $
CapEx (TTM)—
FCF Margin16.07%
FCF Yield—
Net Debt-50.88M $
Net Debt/EBITDA-2.23
Balance Sheet
Debt/Equity—
Current Ratio10.55
Quick Ratio10.27
Book Value/Sh4.334 SEK
Cash/Share3.854 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.22.83M
Float121.34M
Insiders9.36%
Institutions24.29%
Technical
SMA 504.279 (+195.5%)
SMA 2006.462 (+95.7%)
Beta1.22
S&P 52W Chg18.16%
Avg Vol (30d)24.51K
Avg Vol (10d)14.08K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—